Acro Biomedical (ACBM) Current Deferred Revenue (2017 - 2025)
Acro Biomedical (ACBM) recorded quarterly Current Deferred Revenue of $20000.0 in Q4 2025, little changed quarter-over-quarter from $20000.0 in Q3 2025, and little changed on a YoY basis from $20000.0 in Q4 2024.
Acro Biomedical (ACBM) Current Deferred Revenue (2017 - 2025) Analysis & Trends
Acro Biomedical's Current Deferred Revenue history runs 9 years deep, the most recent figure standing at $20000.0 for Q4 2025.
- In Q4 2025, Current Deferred Revenue changed 0.0% year-over-year to $20000.0; the TTM figure through Dec 2025 stood at $20000.0 (changed 0.0% YoY), while the FY2025 annual figure was $20000.0, changed 0.0% from the prior year.
- Current Deferred Revenue was $20000.0 for Q4 2025 at Acro Biomedical, roughly flat from $20000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $20000.0 in Q1 2021 to a low of $20000.0 in Q1 2021.
- Historically, Current Deferred Revenue has averaged $20000.0 across 5 years, with a median of $20000.0 in 2021.
- Biggest YoY gain for Current Deferred Revenue was 0.0% in 2021; the steepest drop was 0.0% in 2021.
- A 5-year view of Current Deferred Revenue shows it stood at $20000.0 in 2021, then changed by 0.0% to $20000.0 in 2022, then changed by 0.0% to $20000.0 in 2023, then changed by 0.0% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $20000.0 (Q4 2025), $20000.0 (Q3 2025), and $20000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |